LXR AGONIST

PROBLEM TO BE SOLVED: To provide a new LXR agonist and a medicine containing the LXR agonist as an active component and effective for the prevention and/or treatment of atherosclerosis, arteriosclerosis, etc. SOLUTION: The LXR agonist contains a compound expressed by general formula (1) (wherein R1,...

Full description

Saved in:
Bibliographic Details
Main Authors WATANABE YUICHIRO, TOSAKA AYAKO, NAKAJIMA HISASHI, MATSUDA TAKAYUKI
Format Patent
LanguageEnglish
Published 07.08.2008
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a new LXR agonist and a medicine containing the LXR agonist as an active component and effective for the prevention and/or treatment of atherosclerosis, arteriosclerosis, etc. SOLUTION: The LXR agonist contains a compound expressed by general formula (1) (wherein R1, R2and R3are each a hydrogen atom, a halogen atom, a 1-6C alkyl group, a hydroxy group or a 1-6C alkoxy group; and R4, R5and R6are each independently a hydrogen atom, a halogen atom, a 1-6C alkyl group, a hydroxy group, a 1-6C alkoxy group, an amino group, a 1-6C alkylamino group or the like), its salt or their solvate as an active component. COPYRIGHT: (C)2008,JPO&INPIT
Bibliography:Application Number: JP20070014357